Abstract:Background: CaMKII (Ca2+/calmodulin-dependent kinase II) plays a central role in cardiac ischemia/reperfusion (I/R) injury-an important therapeutic target for ischemic heart disease. In the heart, CaMKII-delta is the predominant isoform and further alternatively spliced into 11 variants. In humans, CaMKII-delta 9 and CaMKII-delta 3, the major cardiac splice variants, inversely regulate cardiomyocyte viability with the former pro-death and the latter pro-survival. However, it is unknown whether specific inhibition of the detrimental CaMKII-delta 9 prevents cardiac I/R injury and, if so, what is the underlying mechanism. Here, we aim to investigate the cardioprotective effect of specific CaMKII-delta 9 inhibition against myocardial I/R damage and determine the underlying mechanisms. Methods: The role and mechanism of CaMKII-delta 9 in cardiac I/R injury were investigated in mice in vivo, neonatal rat ventricular myocytes, and human embryonic stem cell-derived cardiomyocytes. Results: We demonstrate that CaMKII-delta 9 inhibition with knockdown or knockout of its feature exon, exon 16, protects the heart against I/R-elicited injury and subsequent heart failure. I/R-induced cardiac inflammation was also ameliorated by CaMKII-delta 9 inhibition, and compared with the previously well-studied CaMKII-delta 2, CaMKII-delta 9 overexpression caused more profound cardiac inflammation. Mechanistically, in addition to IKK beta (inhibitor of NF-kappa B [nuclear factor-kappa B] kinase subunit beta), CaMKII-delta 9, but not delta 2, directly interacted with I kappa B alpha (NF-kappa B inhibitor alpha) with its feature exon 13-16-17 combination and increased I kappa B alpha phosphorylation and consequently elicited more pronounced activation of NF-kappa B signaling and inflammatory response. Furthermore, the essential role of CaMKII-delta 9 in myocardial inflammation and damage was confirmed in human cardiomyocytes. Conclusions: We not only identified CaMKII-delta 9-IKK/I kappa B-NF-kappa B signaling as a new regulator of human cardiomyocyte inflammation but also demonstrated that specifically targeting CaMKII-delta 9, the most abundant CaMKII-delta splice variant in human heart, markedly suppresses I/R-induced cardiac NF-kappa B activation, inflammation, and injury and subsequently ameliorates myocardial remodeling and heart failure, providing a novel therapeutic strategy for various ischemic heart diseases.

κ Opioid Receptor Agonist Inhibits Myocardial Injury in Heart Failure Rats through Activating Nrf2/HO-1 Pathway and Regulating Ca2+-SERCA2a

Inhibition of Mitochondrial Permeability Transition Pore Opening Mediated by Kappa‐opioid Receptor in Cardioprotection by Remote Preconditioning

[The Study of Effects and Mechanism of U50, 488H on Electrical Coupling During Ischemia in the Perfused Isolated Rat Heart].

[COX-2 mediates U50488H-induced delayed cardioprotection in isolated rat heart].

Interaction between opioid receptor and adrenoceptor signaling in ischemia reperfusion of the isolated rat heart

Role of Losartan and Carvedilol on in Extracellular Signal-Regulated Kinases in Myocardium of Spontaneously Hypertensive Rats

Abstract 11409: Kappa-opioid Stimulation Following Chronic Cardiac Pressure Overload Increases Endothelial Caveolae Formation and Benefits Cardiac Function

Role of Nrf2/ARE Pathway in Morphine Preconditioning to Alleviate Rat Myocardial Ischemia-Reperfusion Injury

NBP Relieves Cardiac Injury and Reduce Oxidative Stress and Cell Apoptosis in Heart Failure Mice by Activating Nrf2/HO-1/Ca2+-SERCA2a Axis

The Effect of Activated Κ-Opioid Receptor (Κ-Or) on the Role of Calcium Sensing Receptor (casr) in Preventing Hypoxic Pulmonary Hypertension Development

RTA 408 Ameliorates Diabetic Cardiomyopathy by Activating Nrf2 to Regulate Mitochondrial Fission and Fusion and Inhibiting NF-κB-mediated Inflammation.

Activation of a GPCR, ORL1 receptor: A novel therapy to prevent heart failure progression

Mitochondrial Dysfunction and Apoptosis Are Attenuated on Κ-Opioid Receptor Activation Through AMPK/GSK-3β Pathway after Myocardial Ischemia and Reperfusion

Kappa-Opioid Receptors Mediate Cardioprotection by Remote Preconditioning

Anti-arrhythmic Effect Mediated by Regulation of Κ-Opioid Receptor Agonist U50,488H on Cx43 is Associated with Inhibition of Calcium Channel

κ‐opioid receptor agonist U50488H attenuates postoperative cognitive dysfunction of cardiopulmonary bypass rats through the PI3K/AKT/Nrf2/HO‐1 pathway

Obeticholic Acid Inhibit Mitochondria Dysfunction Via Regulating ERK1/2-DRP Pathway to Exert Protective Effect on Lipopolysaccharide-Induced Myocardial Injury

The activated caveolin‐3/μ‐opioid receptor complex drives morphine‐induced rescue therapy in failing hearts

Cellular localization and adaptive changes of the cardiac delta opioid receptor system in an experimental model of heart failure in rats

Delayed Uncoupling is Related to Cardioprotection Induced by Kappa-Agonist U-50,488H in Rat Heart.

Targeting CaMKII-9 Ameliorates Cardiac Ischemia/Reperfusion Injury by Inhibiting Myocardial Inflammation